Low prevalence and independent prognostic role of del(11q) in Chinese patients with chronic lymphocytic leukemia

Zou, YX; Tang, HN; Zhang, J; Tang, XL; Qin, SC; Xia, Y; Zhu, HY; Qiao, C; Wang, L; Fan, L; Xu, W; Li, JY; Miao, Y

Li, JY; Miao, Y (corresponding author), First Affiliated Hosp Nanjing Med Univ, Dept Hematol, Nanjing 210029, Peoples R China.; Li, JY; Miao, Y (corresponding author), Jiangsu Prov Hosp, Nanjing 210029, Peoples R China.; Li, JY; Miao, Y (corresponding author), Nanjing Med Univ, Key Lab Hematol, Nanjing 210029, Peoples R China.; Li, JY; Miao, Y (corresponding author), Collaborat Innovat Ctr Canc Personalized Med, Nanjing 210029, Peoples R China.; Li, JY; Miao, Y (corresponding author), Pukou CLL

TRANSLATIONAL ONCOLOGY, 2021; 14 (10):

Abstract

The 11q deletion (del(11q)) is a conventional cytogenetic aberration observed in chronic lymphocytic leukemia (CLL) patients. However, the prevalence ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索